Twiga Group LLC leverages the decades of experience of its principals in financing and nurturing emerging life science and biomedical companies. The team’s experience ranges from very early stage and even startup companies to those that have reached a level of operational stability, often with a public listing. Having taken numerous companies through the IPO process (particularly on NASDAQ in the US and AIM in the UK), the team has an intimate knowledge of the steps and challenges encountered during that transition. Twiga Group’s long established relationships with scientists, entrepreneurs, senior pharmaceutical executives, and financial brokers/bankers and analysts makes them well positioned to support the companies within the portfolio.
